TABLE 3.
Baseline characteristics of patients with positive multi-drug resistant organisms.
| AMS | Pre-AMS | p-value | |
|---|---|---|---|
| MDRO infections | 58 (11.03) | 90 (18.48) | <0.001 |
| Sex (male), n (%) | 23 (36.7) | 38 (42.2) | 0.864 |
| Age (mean, IQR), years | 62.5 (53.75–72) | 61.5 (50–71) | 0.560 |
| ICU stay (mean, IQR), days | 11 (9–17) | 11.5 (7–16) | 0.780 |
| Underlying disease, n (%) | |||
| Diabetes mellitus | 14 (24.1) | 9 (10.0) | 0.035 |
| Metastatic cancer | 0 (0) | 1 (1.1) | 1 |
| Liver cirrhosis | 3 (5.17) | 5 (5.56) | 1 |
| Chronic kidney disease | 6 (10.3) | 5 (5.6) | 0.341 |
| Hypoproteinemia | 35 (60.3) | 49 (84.5) | 0.501 |
| MDRO, n (%) | |||
| Acinetobacter baumannii | 11 (18.97) | 23 (25.56) | 0.425 |
| Klebsiella pneumoniae | 37 (63.79) | 73 (81.11) | 0.022 |
| Pseudomonas aeruginosa | 6 (10.34) | 9 (10.00) | 1 |
| MRSA | 8 (13.8) | 8 (8.9) | 0.421 |
| Others | 5 (8.62) | 1 (1.11) | 0.034 |
| Infection site (presumed or confirmed) | |||
| Respiratory | 54 (93.1) | 78 (86.7) | 0.283 |
| Urinary tract | 4 (6.9) | 9 (10.0) | 0.569 |
| Intracranial | 0 (0) | 6 (6.67) | 0.082 |
| Disease severity | |||
| Sepsis | 8 (13.8) | 4 (4.4) | 0.062 |
| Septic shock | 4 (6.9) | 0 (0) | 0.022 |
| APACHE Ⅱ, mean (SD) | 24.60 ± 7.71 | 22.71 ± 5.41 | 0.081 |
MDRO: Multi-drug resistant organism; MRSA: Methicillin-resistant Staphylococcus aureus.